Search Results - "Manning, Sara L."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Tracheostomy Emergencies by Bontempo, Laura J., MD, MEd, Manning, Sara L., MD

    “…Tracheostomy is a common procedure for long-term airway management. Although the overall complication rate is greater than 50%, the incidence of serious…”
    Get full text
    Journal Article
  2. 2

    Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer by Brown, Justin C, Rhim, Andrew D, Manning, Sara L, Brennan, Luke, Mansour, Alexandra I, Rustgi, Anil K, Damjanov, Nevena, Troxel, Andrea B, Rickels, Michael R, Ky, Bonnie, Zemel, Babette S, Courneya, Kerry S, Schmitz, Kathryn H

    Published in PloS one (17-10-2018)
    “…Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Spontaneous Irs1 passenger mutation linked to a gene-targeted SerpinB2 allele by Westrick, Randal J., Mohlke, Karen L., Korepta, Lindsey M., Yang, Angela Y., Zhu, Goujing, Manning, Sara L., Winn, Mary E., Dougherty, Kristiann M., Ginsburg, David

    “…In characterizing mice with targeted disruption of the SerpinB2 gene, we observed animals that were small at birth with delayed growth and decreased life…”
    Get full text
    Journal Article
  5. 5

    Homozygosity for factor V leiden leads to enhanced thrombosis and atherosclerosis in mice by EITZMAN, Daniel T, WESTRICK, Randal J, SHEN, Yuechun, BODARY, Peter F, SHUFANG GU, MANNING, Sara L, DOBIES, Sarah L, GINSBURG, David

    Published in Circulation (New York, N.Y.) (12-04-2005)
    “…Activated protein C resistance due to factor V Leiden (FVL) is a common genetic risk factor for venous thrombosis in humans. Although the impact of FVL on the…”
    Get full text
    Journal Article
  6. 6

    A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma by Thege, Fredrik I, Rupani, Dhwani N, Barathi, Bhargavi Brahmendra, Manning, Sara L, Maitra, Anirban, Rhim, Andrew D, Wörmann, Sonja M

    Published in Cancer research (Chicago, Ill.) (03-08-2022)
    “…Conventional genetically engineered mouse models (GEMM) are time-consuming, laborious, and offer limited spatiotemporal control. Here, we describe the…”
    Get full text
    Journal Article
  7. 7

    Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification by Pratt, Erica D, Cowan, Robert W, Manning, Sara L, Qiao, Edmund, Cameron, Heather, Schradle, Kara, Simeone, Diane M, Zhen, David B

    Published in Analytical chemistry (Washington) (18-06-2019)
    “…Oncology research is increasingly incorporating molecular detection of circulating tumor DNA (ctDNA) as a tool for cancer surveillance and early detection…”
    Get full text
    Journal Article
  8. 8

    Adar1 deletion causes degeneration of the exocrine pancreas via Mavs-dependent interferon signaling by Rupani, Dhwani N, Thege, Fredrik I, Chandra, Vidhi, Rajaei, Hajar, Cowan, Robert W, Wörmann, Sonja M, Le Roux, Olivereen, Malaney, Prerna, Manning, Sara L, Hashem, Jack, Bailey-Lundberg, Jennifer, Rhim, Andrew D, McAllister, Florencia

    Published in Development (Cambridge) (15-01-2023)
    “…Adenosine deaminase acting on RNA 1 (ADAR1) is an RNA-binding protein that deaminates adenosine (A) to inosine (I). A-to-I editing alters post-transcriptional…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden by EITZMAN, Daniel T, WESTRICK, Randal J, XIAOMING BI, MANNING, Sara L, WILKINSON, John E, BROZE, George J, GINSBURG, David

    Published in Circulation (New York, N.Y.) (07-05-2002)
    “…Factor V Leiden (FVL) is a common genetic risk factor for thrombosis in humans. The incomplete penetrance of FVL suggests important contributions from other…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    A Sensitized Genome-Wide ENU Mutagenesis Screen in the Mouse to Identify Genetic Modifiers of Thrombosis by Westrick, Randal J., Manning, Sara L., Dobies, Sarah L., Peterson, Abigail L., Siemieniak, David R., Korepta, Lindsey M., Ginsburg, David

    Published in Blood (16-11-2004)
    “…Factor V Leiden, (FVL) is the most common known inherited thrombotic risk factor and is present in approximately 5% of most Western populations and 25–50% of…”
    Get full text
    Journal Article